EDITORIAL
Published on 04 Apr 2022
Editorial: The Mechanisms of Action of Anti-SARS-CoV-2 Drugs
doi 10.3389/fphar.2022.894310
- 1,141 views
- 1 citation
- Frontiers in Pharmacology
- Experimental Pharmacology and Drug Discovery
- Research Topics
- The Mechanisms of Action of Anti-SARS-CoV-2 Drugs
The Mechanisms of Action of Anti-SARS-CoV-2 Drugs
8,528
Total downloads
38k
Total views and downloads
Articles
REVIEW
Published on 25 Feb 2022
Mechanism of Action of Small-Molecule Agents in Ongoing Clinical Trials for SARS-CoV-2: A Review
doi 10.3389/fphar.2022.840639
- 13,616 views
- 27 citations
ORIGINAL RESEARCH
Published on 09 Feb 2022
Effectiveness of Antiviral Therapy in Highly-Transmissible Variants of SARS-CoV-2: A Modeling and Simulation Study
doi 10.3389/fphar.2022.816429
- 4,832 views
- 9 citations
ORIGINAL RESEARCH
Published on 12 Jan 2022
Angiotensin-Converting Enzyme Genotype–Specific Immune Response Contributes to the Susceptibility of COVID-19: A Nested Case–Control Study
doi 10.3389/fphar.2021.759587
- 2,118 views
- 8 citations
ORIGINAL RESEARCH
Published on 05 Jan 2022
Integration Analysis of Pharmacokinetics and Metabolomics to Predict Metabolic Phenotype and Drug Exposure of Remdesivir
doi 10.3389/fphar.2021.779135
- 2,424 views
- 5 citations
BRIEF RESEARCH REPORT
Published on 16 Dec 2021
Low-Dose Fluvoxamine Modulates Endocytic Trafficking of SARS-CoV-2 Spike Protein: A Potential Mechanism for Anti-COVID-19 Protection by Antidepressants
doi 10.3389/fphar.2021.787261
- 5,011 views
- 14 citations
ORIGINAL RESEARCH
Published on 19 Nov 2021
Large Screening Identifies ACE2 Positively Correlates With NF-κB Signaling Activity and Targeting NF-κB Signaling Drugs Suppress ACE2 Levels
doi 10.3389/fphar.2021.771555
- 1,642 views
- 6 citations
ORIGINAL RESEARCH
Published on 26 Aug 2021
Ugonin J Acts as a SARS-CoV-2 3C-like Protease Inhibitor and Exhibits Anti-inflammatory Properties
doi 10.3389/fphar.2021.720018
- 2,277 views
- 15 citations
